国际眼科纵览 ›› 2021, Vol. 45 ›› Issue (5): 386-392.doi: 10.3760/cma.j.issn.1673-5803.2021.05.004

• 综述 • 上一篇    下一篇

结膜黑色素瘤的研究进展

王金锦  李静  马建民   

  1. 首都医科大学附属北京同仁医院  北京同仁眼科中心  眼科学与视觉科学北京市重点实验室 100730
  • 收稿日期:2021-02-02 出版日期:2021-10-22 发布日期:2021-10-25
  • 通讯作者: 马建民,Email:jmma@sina.com
  • 基金资助:
    北京市医院管理中心登峰计划专项经费(DFL20190201);北京市自然科学基金(7182038);国家自然科学基金青年项目(81800864) 

Research progress on conjunctival melanoma

Wang Jinjin,  Li Jing,  Ma Jianmin   

  1. Department of Ophthalmology,  Beijing Tongren Eye Center,  Beijing Tongren Hospital,  Capital Medical University; Beijing  Key Laboratory of Ophthalmology and Visual Science,  Beijing 100730,  China
  • Received:2021-02-02 Online:2021-10-22 Published:2021-10-25
  • Contact: Ma Jianmin, Email: jmma@sina.com
  • Supported by:
    Beijing Hospital Management Center "Climbing peak" Project Special Fund Support (DFL20190201); Beijing Natural Science Foundation (7182038); Natural Science Foundation of China Project (81800864) 

摘要: 结膜黑色素瘤(conjunctival melanoma,CM)是一种罕见的肿瘤,其相关死亡率为30%,在结膜恶性肿瘤中预后最差。CM由结膜上皮基底层的黑色素细胞恶变而来,在此之前可见相应结膜的色素性病变如原发性获得性黑变病及结膜色素痣,最常见于球结膜或角巩膜缘,也可出现于睑结膜。CM能向眼球或眼眶侵袭,并可向局部淋巴结、脑及其他器官转移。组织病理学检查为诊断本病的金标准。多数CM可通过手术切除,术后联合辅助治疗可降低局部复发及远处转移的风险。(国际眼科纵览,2020,  45:386-392)

关键词: 结膜黑色素瘤/诊断;结膜黑色素瘤/治疗 

Abstract: Conjunctival melanoma (CM) is a rare tumor with a mortality rate of 30%. This kind of tumor shows the worst prognosis among conjunctival malignant tumors. CM is caused by the malignant transformation of melanocytes in the basal layer of conjunctival epithelium. In some patients,  the corresponding conjunctival pigmented lesions before conjunctival melanoma,  such as primary pigmented melanosis and conjunctival pigmented nevus can be found. It is most common in the bulbar conjunctiva or corneoscleral margin,  but also in the palpebral conjunctiva. CM can invade the eyeball or orbit,  and metastasize to local lymph nodes,  brain and other organs. Histopathological examination is the gold standard for diagnosis. Most CM can be resected with surgery. Postoperative adjuvant therapy can reduce the risk of local recurrence and distant metastasis.(Int Rev Ophthalmol, 2020, 45: 386-392)

Key words: conjunctival melanoma/diagnosis, conjunctival melanoma/treatment ,